BioCentury
ARTICLE | Emerging Company Profile

BigHat: AI for antibody optimization beyond target engagement

Emerging Company Profile: $19M a16z-led round to support antibody optimization platform

February 11, 2021 1:31 AM UTC

BigHat, which raised $19 million in an A round led by Andreessen Horowitz on Wednesday, is marrying lab assays with machine learning to optimize antibodies for properties beyond target ...



Access this Article